Literature DB >> 18617645

Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults.

Alexander M Strasak1, Cecily C Kelleher, Jochen Klenk, Larry J Brant, Elfriede Ruttmann, Kilian Rapp, Hans Concin, Günter Diem, Karl P Pfeiffer, Hanno Ulmer.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the association of longitudinal change in serum gamma-glutamyltransferase (GGT) with mortality from cardiovascular disease (CVD). METHODS AND
RESULTS: A population-based cohort of 76,113 Austrian men and women with 455,331 serial GGT measurements was prospectively followed-up for a median of 10.2 years after assessment of longitudinal GGT change during an average period of 6.9 years. Cox proportional hazards regression with time-varying covariates was used to evaluate GGT change as an independent predictor for CVD death. Independently of baseline GGT and other classical CVD risk factors, a pronounced increase in GGT (7-year change >9.2 U/L) was significantly associated with increased total CVD mortality in men (P=0.005); the adjusted hazard ratio (95% confidence interval) in comparison to stable GGT (7-year change -0.7 to 1.3 U/L) was 1.40 (1.09 to 1.81). Similarly, total CVD risk was elevated for increasing GGT in women, although effects were less pronounced and statistically significant only in subanalyses regarding coronary heart disease. Age of participants significantly modified the relation between GGT change and CVD mortality, with markedly stronger associations to be observable for younger individuals.
CONCLUSIONS: Our study is the first to demonstrate that a longitudinal increase in GGT, independently of baseline GGT and even within its normal range, significantly increases risk of fatal CVD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617645      PMCID: PMC2643843          DOI: 10.1161/ATVBAHA.108.170597

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  41 in total

1.  Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort.

Authors:  K J Mukamal; P P Jadhav; R B D'Agostino; J M Massaro; M A Mittleman; I Lipinska; P A Sutherland; T Matheney; D Levy; P W Wilson; R C Ellison; H Silbershatz; J E Muller; G H Tofler
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

Review 2.  Gamma glutamyl transferase.

Authors:  J B Whitfield
Journal:  Crit Rev Clin Lab Sci       Date:  2001-08       Impact factor: 6.250

3.  Recent trends and sociodemographic distribution of cardiovascular risk factors: results from two population surveys in the Austrian WHO CINDI demonstration area.

Authors:  H Ulmer; G Diem; H P Bischof; E Ruttmann; H Concin
Journal:  Wien Klin Wochenschr       Date:  2001-08-16       Impact factor: 1.704

4.  Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction.

Authors:  M Emdin; C Passino; C Michelassi; F Titta; A L'abbate; L Donato; A Pompella; A Paolicchi
Journal:  Eur Heart J       Date:  2001-10       Impact factor: 29.983

5.  Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke.

Authors:  P Jousilahti; D Rastenyte; J Tuomilehto
Journal:  Stroke       Date:  2000-08       Impact factor: 7.914

6.  Gamma glutamyltransferase and long-term survival: is it just the liver?

Authors:  Lili Kazemi-Shirazi; Georg Endler; Stefan Winkler; Thomas Schickbauer; Oswald Wagner; Claudia Marsik
Journal:  Clin Chem       Date:  2007-03-23       Impact factor: 8.327

7.  Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II.

Authors:  E R De Oliveira E Silva; D Foster; M McGee Harper; C E Seidman; J D Smith; J L Breslow; E A Brinton
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

Review 8.  Free radicals in the physiological control of cell function.

Authors:  Wulf Dröge
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

9.  Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.

Authors:  Douglas S Lee; Jane C Evans; Sander J Robins; Peter W Wilson; Irene Albano; Caroline S Fox; Thomas J Wang; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-09       Impact factor: 8.311

10.  Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population.

Authors:  C Meisinger; A Döring; A Schneider; H Löwel
Journal:  Atherosclerosis       Date:  2006-02-17       Impact factor: 5.162

View more
  37 in total

1.  Serum γ-glutamyltranspeptidase predicts all-cause, cardiovascular and liver mortality in older adults.

Authors:  Rohit Loomba; Iliana Doycheva; Ricki Bettencourt; Benjamin Cohen; Christina L Wassel; David Brenner; Elizabeth Barrett-Connor
Journal:  J Clin Exp Hepatol       Date:  2013-03-01

Review 2.  Gamma-glutamyl transferase and cardiovascular disease.

Authors:  Gjin Ndrepepa; Adnan Kastrati
Journal:  Ann Transl Med       Date:  2016-12

Review 3.  Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.

Authors:  Enzo Bonora; Giovanni Targher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-08       Impact factor: 46.802

4.  Semiparametric Stochastic Modeling of the Rate Function in Longitudinal Studies.

Authors:  Bin Zhu; Jeremy M G Taylor; Peter X-K Song
Journal:  J Am Stat Assoc       Date:  2011-12-01       Impact factor: 5.033

5.  Oxidized LDL, Gamma-Glutamyltransferase and Adverse Outcomes in Older Adults.

Authors:  Belinda Spoto; Francesco Mattace-Raso; Eric J Sijbrands; Graziella D'Arrigo; Giovanni Tripepi; Stefano Volpato; Stefania Bandinelli; Luigi Ferrucci; Carmine Zoccali
Journal:  J Am Geriatr Soc       Date:  2017-04       Impact factor: 5.562

6.  Increased serum gamma-glutamyltransferase levels are associated with ventricular instability in type 2 diabetes.

Authors:  Kun Wang; Ling Li; Yang Wu; Yu Yang; Jie Chen; Danyu Zhang; Zhoujun Liu; Juan Xu; Meng Cao; Xiaodong Mao; Chao Liu
Journal:  Endocrine       Date:  2015-10-03       Impact factor: 3.633

7.  Short-term changes in liver tests predict long-term mortality.

Authors:  Eliana Saffouri; Eugénie S Lim; Susan W Kim; Paul Hakendorf; Campbell H Thompson
Journal:  Frontline Gastroenterol       Date:  2016-03-08

8.  Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study.

Authors:  Maria Franzini; Irene Fornaciari; Jian Rong; Martin G Larson; Claudio Passino; Michele Emdin; Aldo Paolicchi; Ramachandran S Vasan
Journal:  Clin Chim Acta       Date:  2012-12-14       Impact factor: 3.786

9.  Fenofibrate in primary biliary cirrhosis: a pilot study.

Authors:  E N Liberopoulos; M Florentin; M S Elisaf; D P Mikhailidis; E Tsianos
Journal:  Open Cardiovasc Med J       Date:  2010-04-28

10.  Quantitative loci regulating plasma levels of gamma glutamyl transferase and albumin and their genetic correlations with cardiovascular risk factors.

Authors:  Tanushree Bose; V Saroja Voruganti; M Elizabeth Tejero; J Michael Proffitt; Laura A Cox; John L VandeBerg; Michael C Mahaney; Jeffrey Rogers; Jeanne H Freeland-Graves; Shelley A Cole; Anthony G Comuzzie
Journal:  Exp Biol Med (Maywood)       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.